Clinical trial
Varenicline and Smoking Cessation in Schizophrenia
NCT01111149 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Varenicline and Smoking Cessation in Schizophrenia
- Lead sponsor
- University of Minnesota
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- August 31, 2012
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schizophrenia, smoking cessation